Src family nonreceptor tyrosine kinases are an integral component of the signal transduction apparatus employed by growth factor receptor tyrosine kinases. As such, their role in cellular growth control and malignant transformation has been the subject of intensive investigation. In contrast, classical G-protein-coupled receptor (GPCR) signaling involves activation of second messenger-regulated serine/threonine kinases or ion channels, and is primarily involved in neurotransmission and the shortterm regulation of intermediary metabolism. Over the past decade, this strictly dichotomous model of transmembrane signaling has been challenged by the discovery that GPCRs also exert control over cellular growth, proliferation, and differentiation, and do so by stimulating tyrosine phosphorylation cascades. Several mechanisms, from the direct association of Src family kinases with GPCRs or receptor-associated proteins, to the transactivation of receptor tyrosine kinases and focal adhesion complexes by G-protein-mediated signals, permit GPCRs to activate Src family kinases. Conversely, Src activity plays a central role in controlling GPCR trafficking and effects on cell proliferation and cytoskeletal rearrangement. It is now clear that GPCRs and Src family kinases do not belong to separate, exclusive clubs. Rather, these strange bedfellows are intimately involved in multilayered forms of crosstalk that influence a host of cellular processes.
cytoskeletal rearrangement, and vesicle trafficking by cell surface receptors. Oncogenic v-Src or constitutively activated mutants of c-Src can fully transform murine fibroblasts, and Src activity is frequently upregulated in human malignancies. Native Src family kinases are activated following stimulation of many growth factor receptor tyrosine kinases, and are a key component of the signaling complexes assembled following receptor autophosphorylation (Bromann, 2004) . In addition, the interaction of Src family kinases with focal adhesion kinases, such as FAK and Pyk2, targets them to focal adhesions, where they play an essential role in the cytoskeletal changes and signaling events that result from activation of integrins (Playford and Schaller, 2004; Reynolds and Roczniak-Ferguson, 2004) .
As intracellular proteins with no direct means of detecting changes in the extracellular milieu, the activation and function of Src family kinases is regulated by their recruitment to cell surface receptors. Targeting of Src family kinases is accomplished through protein-protein interactions involving the phosphotyrosine-binding Src homology domain 2 (SH2) and proline-rich domain-binding SH3 domains common to all members of the family (Boggon and Eck, 2004) . The result is that Src signaling occurs in the context of stable multiprotein complexes in which the activated receptor provides a scaffold whose role is to recruit an assortment of enzymatic effectors.
Unlike most other classes of cell surface receptors, heterotrimeric guanine nucleotide-binding protein (Gprotein)-coupled receptors (GPCRs) are classically thought to signal catalytically, by acting as ligandactivated guanine nucleotide exchange factors (GEFs) for heterotrimeric guanine nucleotide-binding (G) proteins. The binding of a 'first messenger' hormone triggers conformational changes that promote receptor-G-protein coupling and catalyse the exchange of GTP for GDP on the Ga subunit of the heterotrimeric G protein, leading to dissociation of the GTP-bound Ga subunit from the Gbg subunit heterodimer. Once dissociated, free Ga-GTP and Gbg subunits regulate the activity of enzymatic effectors, such as adenylate cyclases, phospholipase Cb isoforms, and ion channels, leading to the generation of small molecule 'second messengers'. Second messenger-dependent protein kinases, such as protein kinase A (PKA) and protein kinase C (PKC), in turn regulate downstream targets through serine/threonine phosphorylation. Signaling continues until the intrinsic GTPase activity of the Ga subunit returns the G protein to the inactive heterotrimeric state. Consistent with this catalytic model of GPCR signaling, it is estimated that a single lightactivated rhodopsin in the rod outer segment can induce the activation of hundreds of transducin molecules.
In contrast to G-protein activation, termination of GPCR signaling does involve the formation of stable multiprotein complexes on the receptor. For most GPCRs, agonist exposure leads to receptor phosphorylation by both second messenger-dependent protein kinases and G-protein-coupled receptor kinases (GRKs). GRK phosphorylation promotes the binding of arrestins, which mediate homologous receptor desensitization by physically uncoupling the receptor from its cognate G proteins. The two nonvisual arrestins b-arrestin 1 (arrestin 2) and b-arrestin 2 (arrestin 3) also act as adapter proteins, linking the receptor to clathrin and the b2-adaptin subunit of the AP-2 complex. This causes receptor clustering in clathrin-coated pits, through which they are removed from the plasma membrane by clathrin-dependent endocytosis (Ferguson, 2001; Luttrell and Lefkowitz, 2002) .
GPCR activation of Src family kinases: when worlds collide
In light of the fundamental differences between GPCR and growth factor receptor signaling, the finding that activating mutations in heptahelical receptors or Ga subunits underlie certain forms of endocrine neoplasia, including hyperfunctioning thyroid adenomas and growth hormone-secreting pituitary adenomas, had to come as a surprise (Dhanasekaran et al., 1995; van Biesen et al., 1996) . Perhaps even more surprising was the fact that the oncogenic potential of GPCRs arose from their ability to stimulate Ras-dependent activation of mitogen-activated protein (MAP) kinases, and that these signals frequently required tyrosine protein phosphorylation carried out by Src family kinases (van Biesen et al., 1995; Luttrell et al., 1996) . It is now recognized that GPCRs influence cell growth or differentiation in a host of common clinical disorders, among them pressure overload cardiac hypertrophy, neointimal hyperplasia of vascular smooth muscle and prostate hypertrophy.
Early experiments demonstrated that Src, Fyn or Yes could be activated by a host of GPCRs, including the lysophosphatidic acid (LPA), a2A adrenergic, M1 muscarinic, M2 muscarinic, a-thrombin, endothelin, angiotensin II, bombesin, bradykinin, and V2 vasopressin receptors (Simonson and Herman, 1993; Chen et al., 1994; Ishida et al., 1995; Kramer et al., 1995; Linseman et al., 1995; Ptasznik et al., 1995; Luttrell et al., 1996; Rodriguez-Fernandez and Rozengurt, 1996; Schieffer et al., 1996; Simonson et al., 1996) . From the outset, there was evidence for heterogeneity in the mechanisms underlying GPCR control of Src activity. Src activation by GPCRs coupled predominantly to pertussis toxinsensitive Gi/o family G proteins, like the LPA and a2A adrenergic receptors, is inhibited by the expression of peptides that sequester Gbg subunits, whereas Gq/11-coupled receptors like the M1 muscarinic and angiotensin II receptors mediate Ga subunit-dependent Src activation. In some cases, the activity of receptor tyrosine kinases (Daub et al., 1996; Luttrell et al., 1997) , or the integrity of focal adhesions (Lev et al., 1995; Della Rocca et al., 1997) is required, suggesting that Src activation can arise from crosstalk between GPCRs and other membrane receptors capable of recruiting Src family kinases.
While still incompletely understood, this early evidence of heterogeneity and crosstalk has been substantiated. Several mechanisms of GPCR-mediated Src activation have been described, and prominent among them are forms of receptor crosstalk in which GPCRderived signals activate Src family kinases associated with either receptor tyrosine kinases or focal adhesions. In addition, Src family kinases appear to associate with, and be activated by, GPCRs themselves, either through direct interaction with intracellular receptor domains or by binding to GPCR-associated proteins, such as heterotrimeric G-protein subunits or b-arrestins.
Direct mechanisms: activation of Src family kinases through binding to GPCRs, G proteins, and arrestins Activated Src family kinases are not free. Rather, Src activation occurs in the context of signaling complexes in which Src is bound, through either SH2 or SH3 domain-mediated interactions, to a receptor or scaffolding protein. An evolving body of data suggests that some GPCRs and G-protein subunits directly regulate Src activity. In addition, b-arrestins bound to 'desensitized' GPCRs provide docking sites for Src family kinases, and in so doing, recruit Src as part of a GPCR signaling complex. The proposed models of direct Src regulation by GPCRs are depicted schematically in Figure 1 .
Src family kinase binding to GPCR intracellular domains
In a few cases, Src family kinases may associate directly with the intracellular domains of a GPCR. Several GPCRs contain consensus SH3 domain-binding motifs within their third intracellular loops or C-terminal tails. The b3 adrenergic receptor is one example. The receptor does not contain GRK phosphorylation sites, does not bind b-arrestins, and fails to endocytose upon receptor activation. However, ligand binding induces the formation of a complex between Src and the receptor. This association is mediated through proline-rich motifs in the third intracellular loop and carboxy-terminus of the receptor, which serve as docking sites for the Src SH3 domain. Src association is apparently required for MAP kinase activation by the b3 receptor, since cells expressing receptors mutated in these proline-rich regions fail to bind Src and do not activate MAP kinase (Cao et al., 2000) . A similar result has been observed with the purinergic P2Y2 receptor in 1321N1cells, where two proline-rich regions in the C-terminal tail of the receptor bind the Src SH3 domain (Liu et al., 2004) . Activated Src associates with the receptor following ligand stimulation, and this binding is abolished by deletion of the SH3 binding sites. Interestingly, Src association with the receptor is not involved in either calcium mobilization or extracellular signal-regulated kinase (ERK) activation in these cells.
There is also some evidence that tyrosine phosphorylation of GPCRs plays a role in mediating some GPCR-Src interactions. In studies carried out in A431 epidermoid carcinoma cells, stimulation of the b2 adrenergic receptor with isoproterenol results in tyrosine phosphorylation of the receptor on Tyr-305 (Fan et al., 2001) . Mutation of this residue to phenylalanine abolishes Src association with the receptor and impairs receptor desensitization. This residue lies within a canonical Src SH2 binding site, and the authors propose that Src directly binds the tyrosine-phosphorylated b2 adrenergic receptor.
Src family kinase regulation by heterotrimeric G proteins
Some data suggest that direct interactions between Src and Ga subunits regulate Src activity. In the basal state, the catalytic activity of Src is inhibited by two sets of intramolecular interaction, one between a C-terminal tyrosine (Tyr-530) and the Src SH2 domain, and the second between a proline-rich region adjacent to the kinase domain and the SH3 domain. Phosphorylation of Tyr-530 by the C-terminal Src tyrosine kinase, CSK, promotes pY-530 binding to the SH2 domain and suppresses the catalytic activity of the enzyme (Nada et al., 1991) . Numerous proteins that interact with either the SH2 or SH3 domain of Src family kinases activate the kinase by disrupting these intramolecular interactions (Cooper and Howell, 1993; Saksela et al., 1995;  Alexandropoulos and Baltimore, 1996; Moarefi et al., 1997; Shalloway and Taylor, 1997) . In vitro, incubation of Tyr-530 phosphorylated Src with GTP-gS-bound Gas and Gai, but not with GTP-gS-bound Gaq, Ga12, or free Gbg, results in significant activation of kinase (Ma et al., 2000) . The activation appears to involve binding of the switch II region of the Ga subunit with the catalytic, but not the SH2 or SH3, domains of c-Src, suggesting that the interaction indirectly disrupts the intramolecular associations that hold basal c-Src activity in check. While the physiologic relevance of Src activation by Ga subunits is unclear, these findings suggest the intriguing possibility that Src family kinases may function as G-protein-regulated effectors, in a manner analogous to adenylyl cyclases or phospholipase Cb isoforms.
There is substantial evidence that Src family kinases can return the favor and regulate the activity of Ga subunits through tyrosine phosphorylation. Early studies with murine fibroblasts stably overexpressing wildtype avian c-Src showed that stimulation of the b adrenergic agonist isoproterenol resulted in a threefold increase in cAMP levels relative to that induced in nontransfected cells or cells expressing catalytically inactive Src (Bushman et al., 1990 . The enhanced response to b-agonists requires both an intact Src SH2 domain and the presence of Ser-12 and Ser-48, sites of PKC phosphorylation in the kinase (Moyers et al., 1993) . In vitro analysis suggests that Src affects G-protein regulation of adenylyl cyclase at two points, a stimulatory effect at the level of G-protein activation, and a modest inhibitory effect at the level of adenylyl cyclase itself. Src is capable of phosphorylating a number Ga subunits in vitro, including Gas, Gai1, Gai2, Go, and transducin. The preferred substrate is the inactive GDP-bound Ga subunit, and phosphorylation results in a modest increase in both basal and ligand-induced GTP binding and hydrolysis . Two sites for in vitro phosphorylation on Gas by Src have been identified as Tyr-37, near the site of Gbg binding, GDP Figure 1 Src family kinases as direct effectors of GPCR signaling. Hormone (H) binding to a GPCR catalyses GTP for GDP exchange on heterotrimeric G-protein Ga subunits, G-protein dissociation, and activation of effectors (E) by free Ga-GTP and Gbg subunits. Desensitization of activated receptors involves phosphorylation by GRKs, which promotes b-arrestin (b-arr) binding. GPCR-bound b-arrestins also bind to clathrin and the b2-adaptin (AP-2) subunit, leading to receptor clustering in clathrin-coated pits and dynamin (dyn)-dependent endocytosis. Recruitment and activation of Src family kinases, caused by binding to proline-rich motifs in the intracellular domains of certain GPCRs or interaction with Ga subunits, have been described. In addition, Src family kinases can bind to arrestins, which confers tyrosine kinase activity upon a complex assembled on the desensitized GPCR dissociation and GTP activation, and Tyr-377, in the region of receptor interaction (Moyers et al., 1995) . Similar results have been observed for Gaq/11 phosphorylation. v-Src transformation of fibroblasts increases endothelin-1-induced phosphatidyl inositol hydrolysis (Liu et al., 1996) , and is associated with tyrosine phosphorylation of Gaq/11. Endothelin-1 has also been reported to induce phosphorylation of Gaq/ 11, which can be blocked by either the Src inhibitor, PP2, or by microinjection of antibodies to Yes, but not Src or Fyn (Imamura et al., 2001) . In this case, Yes activity and Gaq/11 phosphorylation appear to play a role in the endothelin receptor-mediated translocation of GLUT4 glucose transporters to the plasma membrane.
b-arrestins as scaffolds for Src family kinase activation
Although the GPCR-G-protein interaction is catalytic, the termination of G-protein coupling engages the receptor in stable protein-protein interactions. Signaling through most GPCRs is regulated by a common desensitizing mechanism involving GRKs and arrestins. Agonist-occupied GPCRs serve as a substrate for GRKs. Once phosphorylated, arrestins bind to the receptors, preventing further G-protein activation and targeting the receptors to clathrin-coated pits (Freedman and Lefkowitz, 1996; Krupnick and Benovic, 1998; Pitcher et al., 1998) . Early studies of GPCRstimulated MAP kinase activation suggested a paradoxical link between the negative regulation of Gprotein coupling and the positive regulation of Rasdependent signaling (Daaka et al., 1998; Ignatova et al., 1999) . The basis for this link appears to be the arrestins. It is now clear that in addition to mediating homologous desensitization and acting as adapters that target GPCRs to clathrin-coated pits, arrestins recruit signaling proteins to ligand-bound GPCRs. Arrestins bind a number of signaling proteins, including Src family tyrosine kinases and components of the ERK1/2 and c-Jun N-terminal kinase (JNK)3 MAP kinase cascades, thereby conferring distinct signaling activities upon the receptor Luttrell and Lefkowitz, 2002; Perry and Lefkowitz 2002) .
The initial evidence suggesting that b-arrestins function as signal transducers was the observation that barrestin 1 and b-arrestin 2 can bind directly to Src and recruit it to agonist-occupied GPCRs. In HEK-293 cells, stimulation of b2 adrenergic receptors results in colocalization of the receptor with both endogenous b-arrestins and Src family kinases in clathrin-coated pits . Src complexed with b-arrestin 1 is dephosphorylated on the C-terminal regulatory tyrosine, and has increased specific activity. Binding of Src to b-arrestin 1 is complex, and is mediated in part by the interaction of proline-rich motifs in the N-terminus of b-arrestin 1 with the Src SH3 domain, and in part by b-arrestin 1 binding to the N-terminal region of the Src catalytic domain , Miller et al., 2000 . Similar results have been observed with other GPCRs, where b-arrestins are involved in recruiting Src to the neurokinin NK-1 receptor (DeFea et al., 2000) , and the Src family kinases Hck and Fgr to the CXCR-1 chemokine receptor (Barlic et al., 2000) .
The formation of b-arrestin:Src complexes on desensitized GPCRs appears to initiate a 'second wave' of GPCR signaling. In some, but not all, cell types barrestin:Src complex formation is involved in GPCRmediated activation of the ERK1/2 cascade Defea et al., 2000) . Several proteins involved with GPCR desentization, endocytosis, and trafficking are also Src substrates. Src phosphorylates dynamin, a large GTPase that plays a critical role in the fission of nascent clathrin-coated vesicles. Dynamin is tyrosine phosphorylated following stimulation with LPA (Baron et al., 1991) , and Src-mediated phosphorylation is required for b2 adrenergic and M1 muscarinic receptor internalization (Ahn et al., 1999; Werbonat et al., 2000) . Expression of a catalytically inactive Src kinase domain fragment that binds tightly to b-arrestin inhibits GPCR-stimulated dynamin phosphorylation and clathrin-dependent endocytosis, suggesting that b-arrestins may target Src to dynamin in clathrin-coated pits (Miller et al., 2000) . Src phosphorylaton of dynamin increases both dynamin self-assembly and GTPase activity, and is required for epidermal growth factor (EGF)-mediated EGF receptor internalization (Ahn et al., 2002 ).
GRK2 appears to be another important substrate for Src. Src has been shown to phosphorylate GRK2 following activation of either b2-AR or CXCR4 receptors (Sarnago et al., 1999; Fan et al., 2001; Penela et al., 2001) . Src phosphorylation has complex effects on GRK2 function, since tyrosine phosphorylation of GRK2 both increases its intrinsic kinase activity, and targets it for rapid ubiquitination and degradation. Expression of a b-arrestin 1 mutant lacking the putative Src SH3 binding domains inhibits GRK2 phosphorylation and degradation, suggesting that GRK2 phosphorylation requires Src to be in complex with b-arrestin. Src may also indirectly regulate GRK2, since GRK2 is also a substrate for ERK phosphorylation. Phosphorylation of GRK2 by ERK decreases GRK2 translocation to the membrane and markedly reduces GRK2 kinase activity (Pitcher et al., 1999; Elorza et al., 2000 , Penela et al., 2003 . Since Src is required for GPCR activation of ERK in many signaling systems, this may provide yet another mechanism through which it participates in the feedback regulation of GPCR signaling.
Finally, b-arrestin:Src complexes may play a role in exocytic vesicle trafficking. In human granulocytes, activation of the CXCR-1 chemokine receptor by interleukin-8 rapidly induces the formation of complexes between b-arrestin and Hck or Fgr. Granulocytes expressing a mutant b-arrestin 1 lacking the putative Src SH3 binding domains fail to activate Hck and exhibit impaired chemokine-induced degranulation, suggesting that b-arrestins regulate exocytosis in neutrophils by activating Src family tyrosine kinases in response to GPCR stimulation (Barlic et al., 2000) .
Indirect mechanisms: activation of Src family kinases by GPCR crosstalk
Initial efforts to understand how GPCRs stimulated cell proliferation led to the discovery of striking parallels between GPCR signals and those arising from the activation of classical receptor tyrosine kinases. In fibroblasts, stimulation of LPA, a-thrombin, M2 muscarinic, and a2A adrenergic receptors results in tyrosine phosphorylation of adapter proteins such as Shc and Gab1, Ras-GTP exchange, and Ras-dependent activation of the ERK1/2 MAP kinase cascade (Cazaubon et al., 1994; Ohmichi et al., 1994; van Biesen et al., 1995; Chen et al., 1996; Sadoshima and Izumo, 1996) . Shc immunoprecipitates from LPA-stimulated cells contain Ras-GEF activity, and dominant-negative mutants of the Grb2-associated Ras-GEF, Sos1, inhibit GPCRmediated ERK activation, demonstrating that Grb2-mediated recruitment of Sos1 is required for GPCR-mediated Ras activation (van Biesen et al., 1995) . The basis for this convergence is that GPCRs engage in extensive crosstalk with both receptor tyrosine kinases and focal adhesion complexes. By 'transactivating' receptor tyrosine kinases and inducing the assembly of focal adhesion-based Ras activation complexes, GPCRs initiate signaling cascades that involve Src family kinases, not as direct GPCR effectors, but indirectly, through crosstalk with other receptormediated signaling pathways.
GPCR-mediated transactivation of receptor tyrosine kinases
Several receptor tyrosine kinases, including members of the EGF receptor family, EGFR1 and EGFR2, the platelet-derived growth factor receptor, PDGFbR, the insulin-like growth factor type 1 receptor, and the vascular endothelial growth factor receptor, KDR/ Flk-1, are rapidly transactivated following GPCR stimulation (Linseman et al., 1995; Rao et al., 1995; Daub et al., 1996 Daub et al., , 1997 Tsai et al., 1997; Cunnick et al., 1998; Eguchi et al., 1998; Herrlich et al, 1998; Gschwind et al., 2002; Tanimoto et al., 2002; Thuringer et al., 2002) . GPCR-mediated transactivation of EGF receptors frequently accounts for the activation of the ERK1/2 cascade by GPCRs coupled to Gi/o or Gq/11. Indeed, EGF receptors serve as points of convergence for growth regulatory signals arising from many extracellular stimuli. In addition to GPCRs, cytokine receptors, including the growth hormone and prolactin receptors , receptor tyrosine kinases, including the IGF-1 receptor (Roudabush et al., 2000) , integrin engagement (Moro et al., 1998) , phorbol esters (Izumi et al, 1998; Dong and Wiley, 2000) , and even physical stimuli such as membrane depolarization Rosen and Greenberg, 1996; Zwick et al., 1997) and stress produced by ultraviolet and ionizing radiation (Rosette and Karin, 1996; Goldkorn et al., 1997; Dent et al., 1999) , all trigger EGF receptor transactivation.
EGF receptor transactivation occurs too rapidly to be explained on the basis of transcriptionally regulated de novo synthesis of ligand. The best understood mechanism of EGF receptor transactivation is through the autocrine/paracrine generation of EGF receptor ligands via a process termed ectodomain shedding (Prenzel et al., 1999) . Each of the known ligands for the EGF receptor, including EGF, transforming growth factor a (TGFa), heparin-binding (HB)-EGF, amphiregulin, betacellulin and epiregulin, is synthesized as a transmembrane precursor that is proteolysed to produce a soluble growth factor. Of these, amphiregulin, HB-EGF and TGFa have been shown to undergo GPCRstimulated release in various cell types (Schafer et al., 2004) . In fibroblasts, both Gi/o-and Gq/11-coupled receptors activate EGF receptors by generating HB-EGF. For Gi/o-coupled GPCRs, HB-EGF shedding and EGF receptor transactivation involves Gbg subunits, while HB-EGF shedding in response to stimulation of Gq/11-coupled receptors is mediated by Gq/11a subunits. Phospholipase Cb activity and PKC activity are not involved in the release (Prenzel et al., 1999) . Proteolysis of the HB-EGF precursor is mediated by members of the ADAM family of matrix metalloproteases (MMPs), one of which, ADAM 12, has been implicated in GPCR-mediated HB-EGF shedding in the heart (Asakura et al., 2002) .
Since Src family tyrosine kinases are activated downstream of many receptor tyrosine kinases, transactivation provides an indirect mechanism of GPCRstimulated Src activation. Src has a well-established role in EGF receptor signaling. Src phosphorylates the EGFR1 on two tyrosine residues, Tyr-1101 and Tyr-845 (Biscardi et al., 1999; Haskell et al., 2001) . Phosphorylation of Tyr-845 appears to be required for mitogenic signaling by EGF receptors, since cells expressing the Y845F mutant of EGFR1 show markedly decreased DNA synthesis in response to both EGF and LPA. In addition, Src activity plays a key downstream role in GPCR-mediated ERK1/2 activation, by contributing to EGF receptor-dependent tyrosine phosphorylation of Shc and Gab1 Luttrell et al., 1997) .
Less clear is whether Src family kinases play an upstream role in GPCR transactivation of receptor tyrosine kinases. As previously discussed, several potential mechanisms exist for the direct activation of Src by GPCRs. Some studies have reported that inhibiting Src activity blocks GPCR-stimulated EGFR1 phosphorylation, suggesting that Src activation by GPCRs precedes transactivation, while others have not Luttrell et al., 1997; Eguchi et al., 1998) . Interestingly, several of the ADAMs implicated in ectodomain shedding, notably , possess consensus SH3 domain binding motifs within their short intracellular domains, potentially providing a means for regulation by Src family kinases. In a mixed culture system in which a2A adrenergic receptor-expressing 'donor' cells were employed to transactivate EGF receptors in adjacent 'acceptor' cells lacking the GPCR, a2A receptor-mediated ERK activation in the acceptor cell population resulted entirely from the paracrine release of HB-EGF from the donor cells. In this system, the acceptor cell response could be blocked by expressing a catalytically inactive dominant-negative c-Src in either the donor or acceptor cells, suggesting that Src activity was required both for HB-EGF release from the donors and for EGF receptor-mediated ERK activation in the acceptors. In contrast, expression of a Gbg sequestrant peptide blocked the acceptor cell response only when expressed in the donor cells, consistent with a predictable role for the G-protein subunits in HB-EGF release, but not in the activation of the ERK cascade by transactivated EGF receptors (Pierce et al., 2001) . On the other hand, a recent study using the gonadotropinreleasing hormone receptor suggests that Src is involved in EGFR transactivation at a point distal to ligand shedding. Although treatment of cells with the Src family kinase inhibitor, PP2, did prevent gonadotropinreleasing hormone-stimulated EGFR1 transactivation, an inhibitor of gelatinase A and B (MMP 2 and 9) blocked activation of both EGFR1 and Src, placing Src in the pathway somewhere between ligand release and activation of the EGFR1 kinase (Roelle et al., 2003) .
PDGFbR and KDR/Flk-1 also undergo rapid GPCR-stimulated transactivation, but the mechanisms underlying these events are less clear. In L cells, which lack EGF receptor expression, LPA stimulates phosphorylation of PDGFbR, and LPA-stimulated Shc and ERK1/2 phosphorylation is completely blocked by inhibiting the PDGF receptor (Herrlich et al., 1998) . Stimulation of vascular smooth muscle cells with angiotensin II appears to induce phosphorylation of a subpopulation of PDGFbR that are distinct from those activated by direct application of PDGF (Heeneman et al., 2000) . As with EGF receptor transactivation, Src activity may be involved both as an upstream mediator of PDGFbR transactivation (Tanimoto et al., 2002) , and downstream as an intermediate in PDGF receptormediated mitogenesis (Barone and Courtneidge, 1995) . Thus, transactivated PDGF receptors, like EGF receptors, provide a platform through which GPCR stimulation can promote Src-dependent signaling. The potential roles of Src family kinases in transactivation are depicted schematically in Figure 2 .
GPCR-mediated signaling through focal adhesion complexes
Like transactivated receptor tyrosine kinases, focal adhesions can serve as platforms through which GPCRs generate Src-dependent signals. Focal adhesions form when integrin heterodimers, which serve as extracellular matrix receptors, cluster at points of contact between the cell surface and specific matrix proteins, such as fibronectin. Part of this complex, the focal adhesion kinase p125FAK, undergoes tyrosine autophosphorylation after binding b integrin, creating docking sites for several signaling proteins. Activated p125FAK associates with Src and both the Grb2-Sos1 and the Crk-C3G Ras-GEF complexes, and integrin engagement initiates several signals associated with cell proliferation and differentiation, including activation of the ERK1/2 cascade. Src is an essential component of this complex, and can both bind to p125FAK and phosphorylate it, creating additional phosphotyrosine docking sites Figure 2 Activation of Src family kinases by GPCR-stimulated transactivation of receptor tyrosine kinases. The best understood mechanism of crosstalk between GPCRs and receptor tyrosine kinases involves the GPCR-stimulated proteolytic release of ligands, such as HB-EGF, following activation of membrane-associated ADAM family MMPs. Transactivated EGF receptors (EGFR1/2) recruit Shc and the Grb2/mSos complex, allowing them to serve as platforms for the GPCR-induced assembly of a Ras activation complex. Transactivation of EGF receptors accounts for GPCR-stimulated activation of the cRaf-1, MEK1/2, ERK1/2 MAP kinase cascade in many systems. Src family kinases are activated in response to EGF receptor activation, and play an essential downstream role in this form of GPCR signaling. In addition, some evidence suggests that Src plays a role in the poorly understood process of GPCR-stimulated MMP activation, particularly in the Gbg subunit-dependent pathway (Haskell et al., 2001; Reynolds and Roczniak-Ferguson, 2004) .
In quiescent fibroblasts, stimulation of endogenous bombesin, vasopressin, and LPA receptors results in rapid activation and tyrosine phosphorylation of p125FAK (Sinnett-Smith et al., 1993; Hordijk et al., 1994; Rodriguez-Fernandez and Rozengurt, 1998) . This effect is independent of calcium mobilization or PKC activity, but requires cell adhesion and cytoskeletal integrity. Exposure of cells either to peptides containing the motif Arg-Gly-Asp, which block integrin dimerization by mimicking the integrin ligand found in extracellular matrix proteins, or to cytochalasin D, which disrupts the actin cytoskeleton, completely inhibits GPCR-induced p125FAK activation (RodriguezFernandez and Rozengurt, 1998; Slack, 1998) .
In other cell types, notably those of neuronal or hematopoietic origin, the calcium-and PKC-regulated FAK family kinase, Pyk2 (also known as CADTK, CAKb, RAFTK, and FAK2), provides a link between GPCRs and focal adhesion-dependent ERK1/2 activation (Lev et al., 1995) . Pyk2 and p125FAK share approximately 60% sequence identity within their catalytic domain and 40% within their N-and Cterminal domains, but differ significantly in tissue distribution and in their regulation by extracellular stimuli. Unlike p125FAK, activation of the Pyk2 and its homologue CADTK occurs by a two-stage process dependent on both cellular adhesion and a costimulatory calcium-or PKC-dependent signal (Brinson et al., 1998; Li et al., 1998) . Phosphorylation of both Pyk2 and p125FAK occur following cell adhesion in rat aortic smooth muscle cells, but Pyk2 phosphorylation is dramatically enhanced by simultaneous stimulation with calcium ionophore or angiotensin II (Zheng et al., 1998) .
As with p125FAK, Src family kinases are recruited and activated by binding to Pyk2 (Lev et al., 1995; Dikic et al., 1998) . In PC-12 pheochromocytoma cells, bradykinin stimulation induces Pyk2 activation, Src recruitment, Src-mediated Pyk2 phosphorylation, and binding of Grb2. Overexpression of a catalytically inactive mutant of Pyk2 blocks bradykinin and calcium ionophore-mediated ERK activation. Similarly, overexpression of CSK, which inactivates Src family kinases, inhibits both bradykinin-and LPA-stimulated Shc phosphorylation and ERK activation in PC-12 cells. In 293T cells, overexpression of Pyk2 is sufficient to confer robust LPA-stimulated, calcium-dependent ERK activation, while expression of a point mutant of Pyk2 that lacks the autophosphorylation site required for Src SH2 domain binding fails to support ERK activation (Lev et al., 1995; Dikic et al., 1996) . The involvement of Src in GPCR regulation of focal adhesion kinase signaling is summarized in Figure 3 .
These data suggest that focal adhesions, like transactivated receptor tyrosine kinases, provide GPCRs with signaling partners through which to stimulate the assembly of a Ras activation complex. Which pathway predominates would be expected to vary in a highly cellspecific manner. Not surprisingly then, LPA and bradykinin stimulation of ERK1/2 in PC12, Rat-1, and HEK-293 cells shows differential dependence on focal adhesions and EGF receptors (Della . In PC12 cells, GPCR activation of ERK is completely blocked by the tetrapeptide Arg-Gly-AspSer and cytochalasin D, but is insensitive to EGF i ) and activates PKC. In neuronal and hematopoietic cells, Pyk2, an FAK family nonreceptor tyrosine kinase, is activated in response to the rise in intracellular calcium and PKC activity. Pyk2, like p125FAK, binds and activates Src, leading to the assembly of a focal adhesion-based complex containing a number of signaling proteins, such as paxillin, CSK, and the Crk/C3G and Grb2/mSos Ras-GEFs. Recruitment of Ras-GEF activity promotes Ras activation and Ras-dependent stimulation of the cRaf-1, MEK1/2, and ERK1/2 MAP kinase cascade. This form of GPCR-stimulated Src activation is conditional, in that both a calcium/PKC signal and the adhesion-dependent integrity of focal adhesions are necessary for signaling receptor inhibition. In Rat-1 cells, disrupting focal adhesions has no effect on ERK1/2 activation, whereas inhibiting EGF receptors with tyrphostin AG-1748 completely blocks the response. HEK-293 cells exhibit an intermediate phenotype, in which LPA-mediated activation of ERK1/2 is partially sensitive to both focal adhesion and EGF receptor inhibitors. The dependence of GPCR-mediated ERK1/2 activation on intact focal adhesions in all three cells correlated with the level of Pyk2 expression. In each case, ERK1/2 activation was inhibited by the Src kinase inhibitors, herbimycin A and PP1, suggesting that while the scaffold choice may be an intrinsic characteristic of the responding cell, Src family kinases serve as a common intermediate in either pathway.
Perspectives: the future of the relationship
Research over the past decade has firmly established that GPCRs regulate Src family kinase activity and that Src family kinases are intimately involved in transducing a subset of GPCR signals. It is clear that the mechanisms controlling Src activity are heterogeneous and vary extensively between cell types, and it is becoming clearer that the mechanism of Src activation determines its cellular role. Src activated by direct interaction with GPCRs or components of the GPCR signaling machinery, including Ga subunits and barrestins, is most clearly associated with the regulation of G-protein function, receptor desensitization, and endocytosis. Src-dependent phosphorylation of heterotrimeric G proteins may alter their GTPase activity and affect the association of Ga and Gbg subunits. Src phosphorylation modulates GRK2 activity and rate of degradation. Src binding to b-arrestins targets it to clathrin-coated pits, where tyrosine phosphorylation of dynamin promotes self-assembly and stimulates its GTPase activity. Incorporation of Src into putative GPCR 'signalsomes' may have broader signaling roles as well. In some cellular backgrounds, the association of Src family kinases with b-arrestins is involved in GPCRstimulated ERK1/2 activation, and may play a role in initiating EGF receptor transactivation by stimulating ectodomain shedding. GPCR-activated Src also plays a role in exocytosis, affecting neutrophil degranulation and the trafficking of GLUT4-containing vesicles.
GPCRs also activate Src family kinases indirectly, through crosstalk with receptor tyrosine kinases and focal adhesion complexes. Here, GPCR-activated Src plays a different role, often involving activation of Ras signaling. Since these signals involve a second cell membrane receptor, Src activation in this setting is context dependent, allowing crosstalk to serve as a mechanism for integrating diverse inputs from the extracellular environment. Src activated through crosstalk is clearly important to GPCR signaling, precisely because it is important to signaling by the transactivated receptor tyrosine kinases or focal adhesion complex. In cells where transactivated EGF receptors account for GPCR-stimulated ERK1/2 activation, Src activation is vital to GPCR-stimulated cell proliferation. In the focal adhesion, Src activated via p120FAK or Pyk2 probably affects cytoskeletal dynamics and promotes the activation of discrete MAP kinase pools. Thus, while the GPCR signaling has historically been thought to be distinct from the mitogenic/survival signaling involving Src family tyrosine kinases, it is now apparent that GPCRs and Src family kinases function as highly coordinated components of common signaling networks.
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